Vitamin B1 (thiamine) and dementia
Authors:
Open Access
- 11 March 2016
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1367 (1) , 21-30
Abstract
The earliest and perhaps best example of an interaction between nutrition and dementia is related to thiamine (vitamin B1). Throughout the last century, research showed that thiamine deficiency is associated with neurological problems, including cognitive deficits and encephalopathy. Multiple similarities exist between classical thiamine deficiency and Alzheimer's disease (AD) in that both are associated with cognitive deficits and reductions in brain glucose metabolism. Thiamine‐dependent enzymes are critical components of glucose metabolism that are reduced in the brains of AD patients and by thiamine decline, and a decrease in their levels could account for the reduction in glucose metabolism. In preclinical models, reduced thiamine can drive AD‐like abnormalities, including memory deficits, neuritic plaques, and hyperphosphorylation of tau. Furthermore, excess thiamine diminishes AD‐like pathologies. In addition to dietary deficits, drugs or other manipulations that interfere with thiamine absorption can cause thiamine deficiency. Elucidating the reasons why the brains of AD patients are functionally thiamine deficient and determining the effects of thiamine restoration may provide critical information to help treat patients with AD.Keywords
Funding Information
- Alzheimer's Drug Discovery Foundation and the National Institutes of Health/National Institute on Aging (R01AG043679, PP-AG14930)
This publication has 54 references indexed in Scilit:
- Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetesMolecular and Cellular Neuroscience, 2013
- Cognition, glucose metabolism and amyloid burden in Alzheimer's diseaseNeurobiology of Aging, 2012
- Thiamine Status in Humans and Content of Phosphorylated Thiamine Derivatives in Biopsies and Cultured CellsPLOS ONE, 2010
- Thiamine and Oxidants Interact to Modify Cellular Calcium StoresNeurochemical Research, 2010
- Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseNature, 2009
- Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse modelNeurobiology of Aging, 2009
- Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's diseaseNeurochemistry International, 2009
- Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivativesBMC Pharmacology, 2008
- Thiamine therapy in Alzheimer's diseaseMetabolic Brain Disease, 1996
- Abnormality of a Thiamine-Requiring Enzyme in Patients with Wernicke-Korsakoff SyndromeNew England Journal of Medicine, 1977